Leonard Reyno
CIK: 0001528716
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
C4 Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jul 10, 2026CCCC
C4 Therapeutics, Inc.
Exercise(M)Direct15.3K shares- - Jul 10, 2026CCCC
C4 Therapeutics, Inc.
Tax Payment(F)Direct7.4K shares at avg. $4.06$30K - Feb 14, 2026CCCC
C4 Therapeutics, Inc.
Exercise(M)Direct31K shares- - Feb 14, 2026CCCC
C4 Therapeutics, Inc.
Tax Payment(F)Direct16.6K shares at avg. $1.89$31K - Feb 13, 2026CCCC
C4 Therapeutics, Inc.
Award(A)Direct240K shares- - Jan 16, 2026CCCC
C4 Therapeutics, Inc.
Sale(S)Direct10K shares at avg. $2.22$22K - Jul 10, 2025CCCC
C4 Therapeutics, Inc.
Exercise(M)Direct15.3K shares- - Jul 10, 2025CCCC
C4 Therapeutics, Inc.
Tax Payment(F)Direct7.4K shares at avg. $1.99$15K - Feb 14, 2025CCCC
C4 Therapeutics, Inc.
Award(A)Direct87.1K shares- - Feb 14, 2025CCCC
C4 Therapeutics, Inc.
Tax Payment(F)Direct5.1K shares at avg. $3.18$16K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 10, 2026 | CCCC C4 Therapeutics, Inc. | Exercise(M) | 15,325 | - | $0 | Direct |
| Jul 10, 2026 | CCCC C4 Therapeutics, Inc. | Tax Payment(F) | 7,397 | $4.06 | $30,032 | Direct |
| Feb 14, 2026 | CCCC C4 Therapeutics, Inc. | Exercise(M) | 30,950 | - | $0 | Direct |
| Feb 14, 2026 | CCCC C4 Therapeutics, Inc. | Tax Payment(F) | 16,579 | $1.89 | $31,334 | Direct |
| Feb 13, 2026 | CCCC C4 Therapeutics, Inc. | Award(A) | 240,000 | - | $0 | Direct |
| Jan 16, 2026 | CCCC C4 Therapeutics, Inc. | Sale(S) | 10,000 | $2.22 | $22,200 | Direct |
| Jul 10, 2025 | CCCC C4 Therapeutics, Inc. | Exercise(M) | 15,325 | - | - | Direct |
| Jul 10, 2025 | CCCC C4 Therapeutics, Inc. | Tax Payment(F) | 7,382 | $1.99 | $14,690 | Direct |
| Feb 14, 2025 | CCCC C4 Therapeutics, Inc. | Award(A) | 87,100 | - | - | Direct |
| Feb 14, 2025 | CCCC C4 Therapeutics, Inc. | Tax Payment(F) | 5,145 | $3.18 | $16,361 | Direct |
1-10 of 10 transactions
About REYNO LEONARD
REYNO LEONARD (SEC CIK 0001528716) files insider reports with the SEC as Chief Medical Officer of C4 Therapeutics, Inc. (CCCC).
Signal8 holds 6 ownership filings by REYNO LEONARD, all Form 4s, filed between Feb 18, 2025 and Jul 13, 2026. Those filings report 10 transactions, from Feb 14, 2025 to Jul 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on REYNO LEONARD's filings is in WATERTOWN, MA.
Recent filings by REYNO LEONARD
- Jul 10, 2026: Option exercise of CCCC shares (Form 4, code M).
- Jul 10, 2026: Tax withholding of CCCC shares (Form 4, code F).
- Feb 14, 2026: Option exercise of CCCC shares (Form 4, code M).
- Feb 14, 2026: Tax withholding of CCCC shares (Form 4, code F).
- Feb 13, 2026: Grant or award of CCCC shares (Form 4, code A).
Other insiders filing for C4 Therapeutics, Inc. (CCCC)
- Anderson Kenneth Carl, Director
- GROGAN DONNA ROY, Director
- Adams Kendra, Chief Financial Officer
- Hughes Owen, Director
- Hoerter Steven L., Director
- Koppikar Utpal, Director